CNS Drugs Journal Issues Research Articles in January 2022 Edition
January 06, 2022
January 06, 2022
CHAM, Switzerland, Jan. 6 -- CNS Drugs, a journal that says it provides researchers and healthcare professionals with information on the aspects of drug therapies used for the management of neurological and psychiatric disorders, published research articles, including the following topics, in its January 2022 edition:
Leading Article:
* Kalirin as a Novel Treatment Target for Cognitive Dysfunction in Schizophrenia
Review Articles:
* Molecular M . . .
Leading Article:
* Kalirin as a Novel Treatment Target for Cognitive Dysfunction in Schizophrenia
Review Articles:
* Molecular M . . .